Annual Total Debt:
$30.30B+$1.67B(+5.85%)Summary
- As of today (April 13, 2025), AZN annual total debt is $30.30 billion, with the most recent change of +$1.67 billion (+5.85%) on December 31, 2024.
- During the last 3 years, AZN annual total debt has fallen by -$486.00 million (-1.58%).
- AZN annual total debt is now -1.58% below its all-time high of $30.78 billion, reached on December 31, 2021.
Performance
AZN Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$0.00-$31.56B(-100.00%)Summary
- As of today (April 13, 2025), AZN quarterly total debt is $0.00, with the most recent change of -$31.56 billion (-100.00%) on December 31, 2024.
- Over the past year, AZN quarterly total debt has stayed the same.
- AZN quarterly total debt is now -100.00% below its all-time high of $34.55 billion, reached on March 31, 2024.
Performance
AZN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
AZN Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.8% | 0.0% |
| 3 y3 years | -1.6% | -100.0% |
| 5 y5 years | +66.2% | -100.0% |
AZN Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.6% | +5.8% | -100.0% | at low |
| 5 y | 5-year | -1.6% | +66.2% | -100.0% | at low |
| alltime | all time | -1.6% | +6558.2% | -100.0% | at low |
AstraZeneca Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $30.30B(+5.8%) | $0.00(-100.0%) |
| Sep 2024 | - | $31.56B(-5.9%) |
| Jun 2024 | - | $33.53B(-2.9%) |
| Mar 2024 | - | $34.55B(>+9900.0%) |
| Dec 2023 | $28.62B(-2.1%) | $0.00(-100.0%) |
| Sep 2023 | - | $28.58B(-4.2%) |
| Jun 2023 | - | $29.84B(-5.3%) |
| Mar 2023 | - | $31.50B(+8.1%) |
| Dec 2022 | $29.23B(-5.0%) | $29.14B(-0.5%) |
| Sep 2022 | - | $29.30B(-0.8%) |
| Jun 2022 | - | $29.53B(-5.1%) |
| Mar 2022 | - | $31.10B(+1.0%) |
| Dec 2021 | $30.78B(+51.0%) | $30.78B(-3.5%) |
| Sep 2021 | - | $31.91B(+16.1%) |
| Jun 2021 | - | $27.50B(+36.6%) |
| Mar 2021 | - | $20.13B(-1.2%) |
| Dec 2020 | $20.38B(+11.8%) | $20.38B(-8.8%) |
| Sep 2020 | - | $22.34B(+13.1%) |
| Jun 2020 | - | $19.75B(+6.3%) |
| Mar 2020 | - | $18.58B(+1.9%) |
| Dec 2019 | $18.23B(-4.6%) | $18.23B(+0.4%) |
| Sep 2019 | - | $18.16B(-7.8%) |
| Jun 2019 | - | $19.70B(-8.7%) |
| Mar 2019 | - | $21.58B(+12.9%) |
| Dec 2018 | $19.11B(+7.3%) | $19.11B(-8.6%) |
| Sep 2018 | - | $20.91B(+6.3%) |
| Jun 2018 | - | $19.67B(-0.9%) |
| Mar 2018 | - | $19.85B(+11.5%) |
| Dec 2017 | $17.81B(+5.9%) | $17.81B(-0.3%) |
| Sep 2017 | - | $17.85B(-9.5%) |
| Jun 2017 | - | $19.73B(+13.3%) |
| Mar 2017 | - | $17.40B(+3.5%) |
| Dec 2016 | $16.81B(+11.7%) | $16.81B(-4.9%) |
| Sep 2016 | - | $17.68B(+0.6%) |
| Jun 2016 | - | $17.58B(+7.8%) |
| Mar 2016 | - | $16.31B(+8.4%) |
| Dec 2015 | $15.05B(+38.8%) | $15.05B(+37.5%) |
| Sep 2015 | - | $10.95B(-0.6%) |
| Jun 2015 | - | $11.01B(+4.2%) |
| Mar 2015 | - | $10.57B(-2.5%) |
| Dec 2014 | $10.84B(+4.5%) | $10.84B(+9.2%) |
| Sep 2014 | - | $9.93B(-1.5%) |
| Jun 2014 | - | $10.07B(-2.6%) |
| Mar 2014 | - | $10.34B(-0.3%) |
| Dec 2013 | $10.38B(+0.6%) | $10.38B(+1.0%) |
| Sep 2013 | - | $10.28B(-1.1%) |
| Jun 2013 | - | $10.39B(+1.7%) |
| Mar 2013 | - | $10.21B(-1.0%) |
| Dec 2012 | $10.31B(+10.5%) | $10.31B(-5.5%) |
| Sep 2012 | - | $10.91B(+17.1%) |
| Jun 2012 | - | $9.32B(-0.7%) |
| Mar 2012 | - | $9.38B(+0.6%) |
| Dec 2011 | $9.33B(+1.1%) | $9.33B(-1.3%) |
| Sep 2011 | - | $9.45B(-1.4%) |
| Jun 2011 | - | $9.58B(-3.9%) |
| Mar 2011 | - | $9.97B(+8.1%) |
| Dec 2010 | $9.22B(-16.6%) | $9.22B(-15.4%) |
| Sep 2010 | - | $10.91B(+631.9%) |
| Jun 2010 | - | $1.49B(-85.9%) |
| Mar 2010 | - | $10.56B(-4.5%) |
| Dec 2009 | $11.06B(+868.7%) | $11.06B(-3.8%) |
| Sep 2009 | - | $11.50B(-2.7%) |
| Jun 2009 | - | $11.82B(+0.5%) |
| Mar 2009 | - | $11.77B(+930.4%) |
| Dec 2008 | $1.14B | $1.14B(-91.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $13.37B(-10.1%) |
| Jun 2008 | - | $14.87B(-0.9%) |
| Mar 2008 | - | $15.00B(-1.0%) |
| Dec 2007 | $15.16B(+1139.2%) | $15.16B(+5.3%) |
| Sep 2007 | - | $14.40B(-6.5%) |
| Jun 2007 | - | $15.40B(+1243.7%) |
| Mar 2007 | - | $1.15B(-6.3%) |
| Dec 2006 | $1.22B(+1.8%) | $1.22B(+1.7%) |
| Sep 2006 | - | $1.20B(+6.3%) |
| Jun 2006 | - | $1.13B(-7.5%) |
| Mar 2006 | - | $1.22B(+1.8%) |
| Dec 2005 | $1.20B(-5.4%) | $1.20B(-3.5%) |
| Sep 2005 | - | $1.24B(-5.3%) |
| Jun 2005 | - | $1.31B(+9.3%) |
| Mar 2005 | - | $1.20B(-5.4%) |
| Dec 2004 | $1.27B(+178.9%) | $1.27B(+0.3%) |
| Sep 2004 | - | $1.26B(+5.5%) |
| Jun 2004 | - | $1.20B(+218.0%) |
| Mar 2004 | - | $377.00M(-17.1%) |
| Dec 2003 | $455.00M(-46.1%) | $455.00M(>+9900.0%) |
| Sep 2003 | - | $0.00(-100.0%) |
| Jun 2003 | - | $379.05M(>+9900.0%) |
| Mar 2003 | - | $0.00(-100.0%) |
| Dec 2002 | $844.00M(-11.7%) | $844.00M(>+9900.0%) |
| Sep 2002 | - | $0.00(-100.0%) |
| Jun 2002 | - | $817.63M(>+9900.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $956.00M(+13.1%) | $956.00M(>+9900.0%) |
| Sep 2001 | - | $0.00(-100.0%) |
| Jun 2001 | - | $907.66M(>+9900.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $845.38M(-24.5%) | $845.38M(>+9900.0%) |
| Sep 2000 | - | $0.00(-100.0%) |
| Jun 2000 | - | $1.19B(>+9900.0%) |
| Mar 2000 | - | $0.00(-100.0%) |
| Dec 1999 | $1.12B(-1.7%) | $1.12B(-0.4%) |
| Sep 1999 | - | $1.12B(-21.3%) |
| Jun 1999 | - | $1.43B(>+9900.0%) |
| Mar 1999 | - | $0.00(-100.0%) |
| Dec 1998 | $1.14B(-2.9%) | $1.14B(>+9900.0%) |
| Sep 1998 | - | $0.00(-100.0%) |
| Jun 1998 | - | $1.34B(>+9900.0%) |
| Mar 1998 | - | $0.00(-100.0%) |
| Dec 1997 | $1.17B(-5.7%) | $1.17B(>+9900.0%) |
| Sep 1997 | - | $0.00(0.0%) |
| Jun 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) |
| Dec 1996 | $1.24B(-2.0%) | $1.24B(>+9900.0%) |
| Sep 1996 | - | $0.00(0.0%) |
| Jun 1996 | - | $0.00(0.0%) |
| Mar 1996 | - | $0.00(-100.0%) |
| Dec 1995 | $1.27B(+8.5%) | $1.27B(>+9900.0%) |
| Sep 1995 | - | $0.00(-100.0%) |
| Jun 1995 | - | $1.36B(>+9900.0%) |
| Mar 1995 | - | $0.00(-100.0%) |
| Dec 1994 | $1.17B(-36.6%) | $1.17B(>+9900.0%) |
| Sep 1994 | - | $0.00(0.0%) |
| Jun 1994 | - | $0.00(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) |
| Dec 1993 | $1.84B(-46.8%) | $1.84B(>+9900.0%) |
| Sep 1993 | - | $0.00(0.0%) |
| Jun 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00 |
| Dec 1992 | $3.47B(+1.2%) | - |
| Dec 1991 | $3.43B(-1.5%) | - |
| Dec 1990 | $3.48B | - |
FAQ
- What is AstraZeneca annual total debt?
- What is the all time high annual total debt for AstraZeneca?
- What is AstraZeneca annual total debt year-on-year change?
- What is AstraZeneca quarterly total debt?
- What is the all time high quarterly total debt for AstraZeneca?
- What is AstraZeneca quarterly total debt year-on-year change?
What is AstraZeneca annual total debt?
The current annual total debt of AZN is $30.30B
What is the all time high annual total debt for AstraZeneca?
AstraZeneca all-time high annual total debt is $30.78B
What is AstraZeneca annual total debt year-on-year change?
Over the past year, AZN annual total debt has changed by +$1.67B (+5.85%)
What is AstraZeneca quarterly total debt?
The current quarterly total debt of AZN is $0.00
What is the all time high quarterly total debt for AstraZeneca?
AstraZeneca all-time high quarterly total debt is $34.55B
What is AstraZeneca quarterly total debt year-on-year change?
Over the past year, AZN quarterly total debt has changed by $0.00 (0.00%)